| |
|
 |
DGRA INTRANET |
 |
| |
| |
 |
|
| Hier
finden Sie interne Informationen für Mitglieder.
|
 |
|
| |
|
 |
GESCHÄFTSADRESSE: |
 |
| |
| |
 |
|
Adenauerallee 15
D-53111 Bonn
Tel.: 0228 / 368264-6
Fax: 0228 / 368264-7
E-Mail: info@dgra.de
|
 |
|
|
|
 |
|
Modul 08 (WS 2009 / SS 2010)
|
|
Zulassung besonderer Arzneimittelgruppen und nationale Zulassung |
 |
|
Präsenzzeit ca. Stunden: 30 |
|
Studienarbeiten ca. Stunden: 30 |
 |
|
Modulleiter/in:
|
Dr. Christine Mayer-Nicolai,
Darmstadt |
 |
|
Übersicht: |
 |
» Themen Modul 08
» Studienplan Modul 08
» Unterlagen & Referenten Modul 08
|
 |
|
Themen: |
 |
| 1 |
Abridged / Generic Applications with emphasis on administrative processes and content of the dossier in module 1
- Essentially similar and informed consent applications
- Bibliographical Application
- Content of the dossier (modules 1, 2 and specific aspects for modules 3 and 4)
- Line-extensions
- Scientific Advice at the BfArM
- The marketing authorization application form
Exercise on the application form |
| |
|
| 2 |
National applications at BfArM (Prüfung nationaler Zulassungsanträge im BfArM)
- Assessment process, e.g. efficacy (Wirksamkeitsprüfung)
- Clinical Trial reports according to Annex one of Directive 2001/83, Clinical Summary and Overview, relevant aspects in the assessment of clinical part of the dossier, fixed combinations
- Summary of Product Characteristics
- Company Core Data Sheet
- Package leaflet and consultation with target patient groups
- Labelling (Kennzeichnung)
- Specific BfArM requirements (Besonderheiten in den Anforderungen des BfArM und zugehörige Bekanntmachungen)
- Labelling principles in national phases of EU procedures
|
| |
|
| 3 |
Specific aspects in marketing applications procedures for herbal and homeopathic medicinal products (AM der besonderen Therapierichtungen)
- Definitions
- Requirements (AMG, AMPrüfRL, pharmacopoeas)
- Possible MAA/registration procedures and required data on S, Q, E
- Herbal medicinal products
- HMPWP
- Botanical nomenclature
- Extracts (labeling)
- Homeopathic medicinal products
- The homeopathic principle, manufacture according to PhEur
- Registration procedure
- Anthroposophical products (brief introduction)
|
| 4 |
Veterinary products
- Definitions
- Veterinary Legislation in Germany, EU and globally
- EMEA, CVMP, HMA and CMD(v), VICH, Animal Health Industry Associations
- SPC
- Parts of a Dossier - Part I, II, IIIA Safety, IIIB Residues, IV
- Withdrawal Periods
- Ecotoxicity
|
| 5 |
Biomedicinal products - specific legal provisions of drug law
- Introduction to PEI
- Biomedicinal products
- Purpose of specific legal rules
- Specific legal provisions at a glance
|
| 6 |
Vaccines
- Definitions and specific aspects
- Combinations
- Influenza vaccines
- Authorization procedure (brief introduction)
- Vaccine Antigen Master File (VAMF)
|
|
7 |
Blood products
- Specific regulatory aspects for Blood components
- Official Batch Release
- Specific requirements for marketing authorization of blood products (example coagulation factors)
- Plasma Master File
Exercise on blood products |
| |
|
| 8 |
Advanced Therapies
- Relevant Directives, Regulations, Guidelines
- Definition and classification: advanced therapy medicinal products, tissue products, combined products
- Authorization procedures
- Incentives
| |
| |
|
Studienplan: |
 |
| Teil 1: |
|
|
| Freitag |
|
08. Januar 2010 von 8.30 – 18.30 Uhr |
| Samstag |
|
09. Januar 2010 von 8.00 – 16.00 Uhr |
| Teil 2: |
|
|
| Freitag |
|
22. Januar 2010 von 8.30 – 18.30 Uhr |
| Samstag |
|
23. Januar 2010 von 8.00 – 16.00 Uhr | |
| |
|
Modulunterlagen: |
 |
Dieser Bereich ist den Mitgliedern der DGRA vorbehalten.
Wenn Sie Mitglied der DGRA werden möchten, füllen Sie bitte den Mitgliedsantrag aus.
Bitte loggen Sie sich mit Ihren Intranet Zugangsdaten hier ein:
|
| |
| « zurück |
| |
 |
 |
|
|
|
 |
|
|
 |
|
|
 |
|
|
 |
© 2011, DGRA e.V.
Letzte Aktualisierung am: Sonntag, 31.01.2010
|
|
|